Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated to obesity and type 2 diabetes mellitus in a Cameroonian population.

BMC obesity

Mato EPM, Pokam-Fosso PE, Atogho-Tiedeu B, Noubiap JJN, Evehe MS, Djokam-Dadjeu R, Donfack OS, Ngwa EN, Guewo-Fokeng M, Mbacham WF, Sobngwi E, Mbanya JC.
PMID: 27239321
BMC Obes. 2016 May 12;3:26. doi: 10.1186/s40608-016-0104-6. eCollection 2016.

BACKGROUND: Peroxisome proliferator-activated receptor gamma 2 (PPAR-γ2) is a transcription factor with a key role in adipocyte differentiation, lipid storage and glucose homeostasis. The Ala allele of the common Pro12Ala polymorphism in the isoform PPAR-γ2 is at the center...

Cite
Mato EPM, Pokam-Fosso PE, Atogho-Tiedeu B, et al. The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated to obesity and type 2 diabetes mellitus in a Cameroonian population. BMC Obes. 2016;3:26doi: 10.1186/s40608-016-0104-6.
Mato, E. P. M., Pokam-Fosso, P. E., Atogho-Tiedeu, B., Noubiap, J. J. N., Evehe, M. S., Djokam-Dadjeu, R., Donfack, O. S., Ngwa, E. N., Guewo-Fokeng, M., Mbacham, W. F., Sobngwi, E., & Mbanya, J. C. (2016). The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated to obesity and type 2 diabetes mellitus in a Cameroonian population. BMC obesity, 326. https://doi.org/10.1186/s40608-016-0104-6
Mato, Edith Pascale M, et al. "The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated to obesity and type 2 diabetes mellitus in a Cameroonian population." BMC obesity vol. 3 (2016): 26. doi: https://doi.org/10.1186/s40608-016-0104-6
Mato EPM, Pokam-Fosso PE, Atogho-Tiedeu B, Noubiap JJN, Evehe MS, Djokam-Dadjeu R, Donfack OS, Ngwa EN, Guewo-Fokeng M, Mbacham WF, Sobngwi E, Mbanya JC. The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated to obesity and type 2 diabetes mellitus in a Cameroonian population. BMC Obes. 2016 May 12;3:26. doi: 10.1186/s40608-016-0104-6. eCollection 2016. PMID: 27239321; PMCID: PMC4866427.
Copy Download .nbib Format: NLM
Association of the leptin-to-adiponectin ratio with metabolic syndrome in a sub-Saharan African population.

Diabetology & metabolic syndrome

Ayina CNA, Endomba FTA, Mandengue SH, Noubiap JJN, Ngoa LSE, Boudou P, Gautier JF, Mbanya JC, Sobngwi E.
PMID: 28878827
Diabetol Metab Syndr. 2017 Sep 05;9:66. doi: 10.1186/s13098-017-0265-6. eCollection 2017.

BACKGROUND: Worldwide there is an increased prevalence of metabolic syndrome mainly due to life-style modifications, and Africans are not saved of this situation. Many markers have been studied to predict the risk of this syndrome but the most used...

Cite
Ayina CNA, Endomba FTA, Mandengue SH, et al. Association of the leptin-to-adiponectin ratio with metabolic syndrome in a sub-Saharan African population. Diabetol Metab Syndr. 2017;9:66doi: 10.1186/s13098-017-0265-6.
Ayina, C. N. A., Endomba, F. T. A., Mandengue, S. H., Noubiap, J. J. N., Ngoa, L. S. E., Boudou, P., Gautier, J. F., Mbanya, J. C., & Sobngwi, E. (2017). Association of the leptin-to-adiponectin ratio with metabolic syndrome in a sub-Saharan African population. Diabetology & metabolic syndrome, 966. https://doi.org/10.1186/s13098-017-0265-6
Ayina, Clarisse Noël A, et al. "Association of the leptin-to-adiponectin ratio with metabolic syndrome in a sub-Saharan African population." Diabetology & metabolic syndrome vol. 9 (2017): 66. doi: https://doi.org/10.1186/s13098-017-0265-6
Ayina CNA, Endomba FTA, Mandengue SH, Noubiap JJN, Ngoa LSE, Boudou P, Gautier JF, Mbanya JC, Sobngwi E. Association of the leptin-to-adiponectin ratio with metabolic syndrome in a sub-Saharan African population. Diabetol Metab Syndr. 2017 Sep 05;9:66. doi: 10.1186/s13098-017-0265-6. eCollection 2017. PMID: 28878827; PMCID: PMC5584041.
Copy Download .nbib Format: NLM
Metabolic effects of exposure to pesticides during gestation in female Wistar rats and their offspring: a risk factor for diabetes?.

Toxicological research

Ndonwi EN, Atogho-Tiedeu B, Lontchi-Yimagou E, Shinkafi TS, Nanfa D, Balti EV, Katte JC, Mbanya A, Matsha T, Mbanya JC, Shakir A, Sobngwi E.
PMID: 32685429
Toxicol Res. 2020 Feb 04;36(3):249-256. doi: 10.1007/s43188-019-00028-y. eCollection 2020 Jul.

Some pesticides increase the risk of type 2 diabetes, but whether fetal exposure carries transgenerational risk remains unknown. We evaluated the metabolic effects of gestational exposure to chlorpyrifos and imidacloprid in female Wistar rats and their offspring. We studied...

Cite
Ndonwi EN, Atogho-Tiedeu B, Lontchi-Yimagou E, et al. Metabolic effects of exposure to pesticides during gestation in female Wistar rats and their offspring: a risk factor for diabetes?. Toxicol Res. 2020;36(3):249-256doi: 10.1007/s43188-019-00028-y.
Ndonwi, E. N., Atogho-Tiedeu, B., Lontchi-Yimagou, E., Shinkafi, T. S., Nanfa, D., Balti, E. V., Katte, J. C., Mbanya, A., Matsha, T., Mbanya, J. C., Shakir, A., & Sobngwi, E. (2020). Metabolic effects of exposure to pesticides during gestation in female Wistar rats and their offspring: a risk factor for diabetes?. Toxicological research, 36(3), 249-256. https://doi.org/10.1007/s43188-019-00028-y
Ndonwi, Elvis Ngwa, et al. "Metabolic effects of exposure to pesticides during gestation in female Wistar rats and their offspring: a risk factor for diabetes?." Toxicological research vol. 36,3 (2020): 249-256. doi: https://doi.org/10.1007/s43188-019-00028-y
Ndonwi EN, Atogho-Tiedeu B, Lontchi-Yimagou E, Shinkafi TS, Nanfa D, Balti EV, Katte JC, Mbanya A, Matsha T, Mbanya JC, Shakir A, Sobngwi E. Metabolic effects of exposure to pesticides during gestation in female Wistar rats and their offspring: a risk factor for diabetes?. Toxicol Res. 2020 Feb 04;36(3):249-256. doi: 10.1007/s43188-019-00028-y. eCollection 2020 Jul. PMID: 32685429; PMCID: PMC7351921.
Copy Download .nbib Format: NLM
HIV treatment is associated with a two-fold higher probability of raised triglycerides: Pooled Analyses in 21 023 individuals in sub-Saharan Africa.

Global health, epidemiology and genomics

Ekoru K, Young EH, Dillon DG, Gurdasani D, Stehouwer N, Faurholt-Jepsen D, Levitt NS, Crowther NJ, Nyirenda M, Njelekela MA, Ramaiya K, Nyan O, Adewole OO, Anastos K, Compostella C, Dave JA, Fourie CM, Friis H, Kruger IM, Longenecker CT, Maher DP, Mutimura E, Ndhlovu CE, Praygod G, Pefura Yone EW, Pujades-Rodriguez M, Range N, Sani MU, Sanusi M, Schutte AE, Sliwa K, Tien PC, Vorster EH, Walsh C, Gareta D, Mashili F, Sobngwi E, Adebamowo C, Kamali A, Seeley J, Smeeth L, Pillay D, Motala AA, Kaleebu P, Sandhu MS.
PMID: 29881632
Glob Health Epidemiol Genom. 2018;3. doi: 10.1017/gheg.2018.7. Epub 2018 May 08.

BACKGROUND: Anti-retroviral therapy (ART) regimes for HIV are associated with raised levels of circulating triglycerides (TG) in western populations. However, there are limited data on the impact of ART on cardiometabolic risk in sub-Saharan African (SSA) populations.METHODS: Pooled analyses...

Cite
Ekoru K, Young EH, Dillon DG, et al. HIV treatment is associated with a two-fold higher probability of raised triglycerides: Pooled Analyses in 21 023 individuals in sub-Saharan Africa. Glob Health Epidemiol Genom. 2018;3doi: 10.1017/gheg.2018.7.
Ekoru, K., Young, E. H., Dillon, D. G., Gurdasani, D., Stehouwer, N., Faurholt-Jepsen, D., Levitt, N. S., Crowther, N. J., Nyirenda, M., Njelekela, M. A., Ramaiya, K., Nyan, O., Adewole, O. O., Anastos, K., Compostella, C., Dave, J. A., Fourie, C. M., Friis, H., Kruger, I. M., Longenecker, C. T., Maher, D. P., Mutimura, E., Ndhlovu, C. E., Praygod, G., Pefura Yone, E. W., Pujades-Rodriguez, M., Range, N., Sani, M. U., Sanusi, M., Schutte, A. E., Sliwa, K., Tien, P. C., Vorster, E. H., Walsh, C., Gareta, D., Mashili, F., Sobngwi, E., Adebamowo, C., Kamali, A., Seeley, J., Smeeth, L., Pillay, D., Motala, A. A., Kaleebu, P., & Sandhu, M. S. (2018). HIV treatment is associated with a two-fold higher probability of raised triglycerides: Pooled Analyses in 21 023 individuals in sub-Saharan Africa. Global health, epidemiology and genomics, 3. https://doi.org/10.1017/gheg.2018.7
Ekoru, Kenneth, et al. "HIV treatment is associated with a two-fold higher probability of raised triglycerides: Pooled Analyses in 21 023 individuals in sub-Saharan Africa." Global health, epidemiology and genomics vol. 3 (2018). doi: https://doi.org/10.1017/gheg.2018.7
Ekoru K, Young EH, Dillon DG, Gurdasani D, Stehouwer N, Faurholt-Jepsen D, Levitt NS, Crowther NJ, Nyirenda M, Njelekela MA, Ramaiya K, Nyan O, Adewole OO, Anastos K, Compostella C, Dave JA, Fourie CM, Friis H, Kruger IM, Longenecker CT, Maher DP, Mutimura E, Ndhlovu CE, Praygod G, Pefura Yone EW, Pujades-Rodriguez M, Range N, Sani MU, Sanusi M, Schutte AE, Sliwa K, Tien PC, Vorster EH, Walsh C, Gareta D, Mashili F, Sobngwi E, Adebamowo C, Kamali A, Seeley J, Smeeth L, Pillay D, Motala AA, Kaleebu P, Sandhu MS. HIV treatment is associated with a two-fold higher probability of raised triglycerides: Pooled Analyses in 21 023 individuals in sub-Saharan Africa. Glob Health Epidemiol Genom. 2018;3. doi: 10.1017/gheg.2018.7. Epub 2018 May 08. PMID: 29881632; PMCID: PMC5985947.
Copy Download .nbib Format: NLM
Effects of non-surgical treatment of chronic periodontitis on insulin resistance and glucose tolerance in subjects without diabetes (PARODIA 2 study).

Journal of investigative medicine : the official publication of the American Federation for Clinical Research

Nana Nana AR, Tsobgny Tsague NF, Lontchi-Yimagou E, Bengondo Messanga C, Tankeu A, Katte JC, Balti Vounsia E, Dehayem M, Sobngwi E.
PMID: 34261767
J Investig Med. 2021 Oct;69(7):1377-1381. doi: 10.1136/jim-2021-001831. Epub 2021 Jul 14.

This study aimed to assess the effects of non-surgical periodontal treatment (NSPT) of chronic periodontitis on insulin sensitivity, glucose tolerance, and serum C reactive protein (CRP) level in individuals without diabetes. Twenty individuals without diabetes with chronic periodontitis underwent...

Cite
Nana Nana AR, Tsobgny Tsague NF, Lontchi-Yimagou E, et al. Effects of non-surgical treatment of chronic periodontitis on insulin resistance and glucose tolerance in subjects without diabetes (PARODIA 2 study). J Investig Med. 2021;69(7):1377-1381doi: 10.1136/jim-2021-001831.
Nana Nana, A. R., Tsobgny Tsague, N. F., Lontchi-Yimagou, E., Bengondo Messanga, C., Tankeu, A., Katte, J. C., Balti Vounsia, E., Dehayem, M., & Sobngwi, E. (2021). Effects of non-surgical treatment of chronic periodontitis on insulin resistance and glucose tolerance in subjects without diabetes (PARODIA 2 study). Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 69(7), 1377-1381. https://doi.org/10.1136/jim-2021-001831
Nana Nana, Arnel Redon, et al. "Effects of non-surgical treatment of chronic periodontitis on insulin resistance and glucose tolerance in subjects without diabetes (PARODIA 2 study)." Journal of investigative medicine : the official publication of the American Federation for Clinical Research vol. 69,7 (2021): 1377-1381. doi: https://doi.org/10.1136/jim-2021-001831
Nana Nana AR, Tsobgny Tsague NF, Lontchi-Yimagou E, Bengondo Messanga C, Tankeu A, Katte JC, Balti Vounsia E, Dehayem M, Sobngwi E. Effects of non-surgical treatment of chronic periodontitis on insulin resistance and glucose tolerance in subjects without diabetes (PARODIA 2 study). J Investig Med. 2021 Oct;69(7):1377-1381. doi: 10.1136/jim-2021-001831. Epub 2021 Jul 14. PMID: 34261767; PMCID: PMC8485124.
Copy Download .nbib Format: NLM
Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO).

The Pan African medical journal

Dzudie A, Tchounga B, Ajeh R, Kouanfack C, Ebasone PV, Djikeussi T, Nyoto LB, Fokam J, Ateudjieu J, Tchendjou P, Semengue ENJ, Kamgang FY, Anoubessi J, Varloteaux M, Youngui B, Tabala FN, Atanga B, Simo L, Zemsi A, Shu EN, Ndayisaba G, Nyenti A, Ntabe AC, Bwemba TA, Sobngwi E, Billong SC, Ditekemena J, Bissek ACZ, Njock LR.
PMID: 34909092
Pan Afr Med J. 2021 Oct 29;40:124. doi: 10.11604/pamj.2021.40.124.31068. eCollection 2021.

INTRODUCTION: the Treat-All remains the globally endorsed approach to attain the 95-95-95 targets and end the AIDS pandemic by 2030, but requires some country-level contextualization. In Cameroon, the specific research agenda to inform strategies for improving HIV policy was...

Cite
Dzudie A, Tchounga B, Ajeh R, et al. Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO). Pan Afr Med J. 2021;40:124doi: 10.11604/pamj.2021.40.124.31068.
Dzudie, A., Tchounga, B., Ajeh, R., Kouanfack, C., Ebasone, P. V., Djikeussi, T., Nyoto, L. B., Fokam, J., Ateudjieu, J., Tchendjou, P., Semengue, E. N. J., Kamgang, F. Y., Anoubessi, J., Varloteaux, M., Youngui, B., Tabala, F. N., Atanga, B., Simo, L., Zemsi, A., Shu, E. N., Ndayisaba, G., Nyenti, A., Ntabe, A. C., Bwemba, T. A., Sobngwi, E., Billong, S. C., Ditekemena, J., Bissek, A. C. Z., & Njock, L. R. (2021). Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO). The Pan African medical journal, 40124. https://doi.org/10.11604/pamj.2021.40.124.31068
Dzudie, Anastase, et al. "Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO)." The Pan African medical journal vol. 40 (2021): 124. doi: https://doi.org/10.11604/pamj.2021.40.124.31068
Dzudie A, Tchounga B, Ajeh R, Kouanfack C, Ebasone PV, Djikeussi T, Nyoto LB, Fokam J, Ateudjieu J, Tchendjou P, Semengue ENJ, Kamgang FY, Anoubessi J, Varloteaux M, Youngui B, Tabala FN, Atanga B, Simo L, Zemsi A, Shu EN, Ndayisaba G, Nyenti A, Ntabe AC, Bwemba TA, Sobngwi E, Billong SC, Ditekemena J, Bissek ACZ, Njock LR. Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO). Pan Afr Med J. 2021 Oct 29;40:124. doi: 10.11604/pamj.2021.40.124.31068. eCollection 2021. PMID: 34909092; PMCID: PMC8641633.
Copy Download .nbib Format: NLM
The Follow-Up and Well-Being of Geriatric Outpatients During COVID-19 Pandemic in Cameroon: Insights From the Yaounde Central Hospital.

Gerontology & geriatric medicine

Ntsama Essomba MJ, Nzana V, Noubiap JJ, Zingui-Ottou M, Ciaffi L, Sobngwi E, Ashuntantang G.
PMID: 33029549
Gerontol Geriatr Med. 2020 Sep 25;6:2333721420959242. doi: 10.1177/2333721420959242. eCollection 2020.

Although total confinement has not been adopted by the government of Cameroon, the COVID-19 pandemic is keeping geriatric patients out of hospital, despite a decline in their health status. In addition, the pandemic might have a significant effect on...

Cite
Ntsama Essomba MJ, Nzana V, Noubiap JJ, et al. The Follow-Up and Well-Being of Geriatric Outpatients During COVID-19 Pandemic in Cameroon: Insights From the Yaounde Central Hospital. Gerontol Geriatr Med. 2020;6:2333721420959242doi: 10.1177/2333721420959242.
Ntsama Essomba, M. J., Nzana, V., Noubiap, J. J., Zingui-Ottou, M., Ciaffi, L., Sobngwi, E., & Ashuntantang, G. (2020). The Follow-Up and Well-Being of Geriatric Outpatients During COVID-19 Pandemic in Cameroon: Insights From the Yaounde Central Hospital. Gerontology & geriatric medicine, 62333721420959242. https://doi.org/10.1177/2333721420959242
Ntsama Essomba, Marie Josiane, et al. "The Follow-Up and Well-Being of Geriatric Outpatients During COVID-19 Pandemic in Cameroon: Insights From the Yaounde Central Hospital." Gerontology & geriatric medicine vol. 6 (2020): 2333721420959242. doi: https://doi.org/10.1177/2333721420959242
Ntsama Essomba MJ, Nzana V, Noubiap JJ, Zingui-Ottou M, Ciaffi L, Sobngwi E, Ashuntantang G. The Follow-Up and Well-Being of Geriatric Outpatients During COVID-19 Pandemic in Cameroon: Insights From the Yaounde Central Hospital. Gerontol Geriatr Med. 2020 Sep 25;6:2333721420959242. doi: 10.1177/2333721420959242. eCollection 2020. PMID: 33029549; PMCID: PMC7522829.
Copy Download .nbib Format: NLM
Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Kalra S, Czupryniak L, Kilov G, Lamptey R, Kumar A, Unnikrishnan AG, Boudiba A, Abid M, Akanov ZA, Latheef A, Araz M, Audehm R, Bahendeka S, Balde N, Chaudhary S, Deerochanawong C, Fasanmade O, Iraqi H, Latt TS, Mbanya JC, Rodriguez-Saldana J, Hyun KS, Latif ZA, Lushchyk M, Megallaa M, Naseri MW, Bay NQ, Ramaiya K, Randeree H, Raza SA, Shaikh K, Shrestha D, Sobngwi E, Somasundaram N, Sukor N, Tan R.
PMID: 30390228
Diabetes Ther. 2018 Dec;9(6):2185-2199. doi: 10.1007/s13300-018-0521-2. Epub 2018 Nov 03.

Premixed insulins are an important tool for glycemic control in persons with diabetes. Equally important in diabetes care is the selection of the most appropriate insulin regimen for a particular individual at a specific time. Currently, the choice of...

Cite
Kalra S, Czupryniak L, Kilov G, et al. Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care. Diabetes Ther. 2018;9(6):2185-2199doi: 10.1007/s13300-018-0521-2.
Kalra, S., Czupryniak, L., Kilov, G., Lamptey, R., Kumar, A., Unnikrishnan, A. G., Boudiba, A., Abid, M., Akanov, Z. A., Latheef, A., Araz, M., Audehm, R., Bahendeka, S., Balde, N., Chaudhary, S., Deerochanawong, C., Fasanmade, O., Iraqi, H., Latt, T. S., Mbanya, J. C., Rodriguez-Saldana, J., Hyun, K. S., Latif, Z. A., Lushchyk, M., Megallaa, M., Naseri, M. W., Bay, N. Q., Ramaiya, K., Randeree, H., Raza, S. A., Shaikh, K., Shrestha, D., Sobngwi, E., Somasundaram, N., Sukor, N., & Tan, R. (2018). Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care. Diabetes therapy : research, treatment and education of diabetes and related disorders, 9(6), 2185-2199. https://doi.org/10.1007/s13300-018-0521-2
Kalra, Sanjay, et al. "Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 9,6 (2018): 2185-2199. doi: https://doi.org/10.1007/s13300-018-0521-2
Kalra S, Czupryniak L, Kilov G, Lamptey R, Kumar A, Unnikrishnan AG, Boudiba A, Abid M, Akanov ZA, Latheef A, Araz M, Audehm R, Bahendeka S, Balde N, Chaudhary S, Deerochanawong C, Fasanmade O, Iraqi H, Latt TS, Mbanya JC, Rodriguez-Saldana J, Hyun KS, Latif ZA, Lushchyk M, Megallaa M, Naseri MW, Bay NQ, Ramaiya K, Randeree H, Raza SA, Shaikh K, Shrestha D, Sobngwi E, Somasundaram N, Sukor N, Tan R. Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care. Diabetes Ther. 2018 Dec;9(6):2185-2199. doi: 10.1007/s13300-018-0521-2. Epub 2018 Nov 03. PMID: 30390228; PMCID: PMC6250631.
Copy Download .nbib Format: NLM
Setting-up nurse-led pilot clinics for the management of non-communicable diseases at primary health care level in resource-limited settings of Africa.

The Pan African medical journal

Kengne AP, Sobngwi E, Fezeu L, Awah PK, Dongmo S, Mbanya JC.
PMID: 21532719
Pan Afr Med J. 2009 Oct 24;3:10.

BACKGROUND: This article describes the setting-up process for nurse-led pilot clinics for the management of four chronic diseases: asthma, type 2 diabetes mellitus, epilepsy and hypertension at the primary health care level in urban and rural Cameroon.METHODS: The Biyem-Assi...

Cite
Kengne AP, Sobngwi E, Fezeu L, et al. Setting-up nurse-led pilot clinics for the management of non-communicable diseases at primary health care level in resource-limited settings of Africa. Pan Afr Med J. 2009;3:10
Kengne, A. P., Sobngwi, E., Fezeu, L., Awah, P. K., Dongmo, S., Mbanya, J. C. (2009). Setting-up nurse-led pilot clinics for the management of non-communicable diseases at primary health care level in resource-limited settings of Africa. The Pan African medical journal, 310.
Kengne, Andre Pascal, et al. "Setting-up nurse-led pilot clinics for the management of non-communicable diseases at primary health care level in resource-limited settings of Africa." The Pan African medical journal vol. 3 (2009): 10.
Kengne AP, Sobngwi E, Fezeu L, Awah PK, Dongmo S, Mbanya JC. Setting-up nurse-led pilot clinics for the management of non-communicable diseases at primary health care level in resource-limited settings of Africa. Pan Afr Med J. 2009 Oct 24;3:10. PMID: 21532719; PMCID: PMC2984281.
Copy Download .nbib Format: NLM
Erratum to: Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study.

Journal of health, population, and nutrition

Nguimmo-Metsadjio A, Atogho-Tiedeu B, Noubiap JJ, Evehe MS, Djokam-Dadjeu R, Donfack OS, Nanfa D, Mato EPM, Ngwa EN, Guewo-Fokeng M, Pokam-Fosso P, Mbacham WF, Mbanya JC, Sobngwi E.
PMID: 28511671
J Health Popul Nutr. 2017 May 16;36(1):16. doi: 10.1186/s41043-017-0094-0.

No abstract available.

Cite
Nguimmo-Metsadjio A, Atogho-Tiedeu B, Noubiap JJ, et al. Erratum to: Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study. J Health Popul Nutr. 2017;36(1):16doi: 10.1186/s41043-017-0094-0.
Nguimmo-Metsadjio, A., Atogho-Tiedeu, B., Noubiap, J. J., Evehe, M. S., Djokam-Dadjeu, R., Donfack, O. S., Nanfa, D., Mato, E. P. M., Ngwa, E. N., Guewo-Fokeng, M., Pokam-Fosso, P., Mbacham, W. F., Mbanya, J. C., & Sobngwi, E. (2017). Erratum to: Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study. Journal of health, population, and nutrition, 36(1), 16. https://doi.org/10.1186/s41043-017-0094-0
Nguimmo-Metsadjio, Aurelie, et al. "Erratum to: Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study." Journal of health, population, and nutrition vol. 36,1 (2017): 16. doi: https://doi.org/10.1186/s41043-017-0094-0
Nguimmo-Metsadjio A, Atogho-Tiedeu B, Noubiap JJ, Evehe MS, Djokam-Dadjeu R, Donfack OS, Nanfa D, Mato EPM, Ngwa EN, Guewo-Fokeng M, Pokam-Fosso P, Mbacham WF, Mbanya JC, Sobngwi E. Erratum to: Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study. J Health Popul Nutr. 2017 May 16;36(1):16. doi: 10.1186/s41043-017-0094-0. PMID: 28511671; PMCID: PMC5434556.
Copy Download .nbib Format: NLM
Persistent organic pollutants as risk factors for type 2 diabetes.

Diabetology & metabolic syndrome

Ngwa EN, Kengne AP, Tiedeu-Atogho B, Mofo-Mato EP, Sobngwi E.
PMID: 25987904
Diabetol Metab Syndr. 2015 Apr 30;7:41. doi: 10.1186/s13098-015-0031-6. eCollection 2015.

Type 2 diabetes mellitus (T2DM) is a major and fast growing public health problem. Although obesity is considered to be the main driver of the pandemic of T2DM, a possible contribution of some environmental contaminants, of which persistent organic...

Cite
Ngwa EN, Kengne AP, Tiedeu-Atogho B, et al. Persistent organic pollutants as risk factors for type 2 diabetes. Diabetol Metab Syndr. 2015;7:41doi: 10.1186/s13098-015-0031-6.
Ngwa, E. N., Kengne, A. P., Tiedeu-Atogho, B., Mofo-Mato, E. P., & Sobngwi, E. (2015). Persistent organic pollutants as risk factors for type 2 diabetes. Diabetology & metabolic syndrome, 741. https://doi.org/10.1186/s13098-015-0031-6
Ngwa, Elvis Ndonwi, et al. "Persistent organic pollutants as risk factors for type 2 diabetes." Diabetology & metabolic syndrome vol. 7 (2015): 41. doi: https://doi.org/10.1186/s13098-015-0031-6
Ngwa EN, Kengne AP, Tiedeu-Atogho B, Mofo-Mato EP, Sobngwi E. Persistent organic pollutants as risk factors for type 2 diabetes. Diabetol Metab Syndr. 2015 Apr 30;7:41. doi: 10.1186/s13098-015-0031-6. eCollection 2015. PMID: 25987904; PMCID: PMC4435855.
Copy Download .nbib Format: NLM
Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity.

Diabetology & metabolic syndrome

Ayina Ayina CN, Sobngwi E, Essouma M, Noubiap JJ, Boudou P, Etoundi Ngoa LS, Gautier JF.
PMID: 26034511
Diabetol Metab Syndr. 2015 May 23;7:47. doi: 10.1186/s13098-015-0042-3. eCollection 2015.

BACKGROUND: Osteoprotegerin (OPG), a soluble member of the tumor necrosis factor receptor superfamily that inhibits bone resorption, has been suggested as a potential marker of cardiovascular risk. This study aimed to assess the relationship between insulin resistance, lipid profile...

Cite
Ayina Ayina CN, Sobngwi E, Essouma M, et al. Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity. Diabetol Metab Syndr. 2015;7:47doi: 10.1186/s13098-015-0042-3.
Ayina Ayina, C. N., Sobngwi, E., Essouma, M., Noubiap, J. J., Boudou, P., Etoundi Ngoa, L. S., & Gautier, J. F. (2015). Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity. Diabetology & metabolic syndrome, 747. https://doi.org/10.1186/s13098-015-0042-3
Ayina Ayina, Clarisse Noël, et al. "Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity." Diabetology & metabolic syndrome vol. 7 (2015): 47. doi: https://doi.org/10.1186/s13098-015-0042-3
Ayina Ayina CN, Sobngwi E, Essouma M, Noubiap JJ, Boudou P, Etoundi Ngoa LS, Gautier JF. Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity. Diabetol Metab Syndr. 2015 May 23;7:47. doi: 10.1186/s13098-015-0042-3. eCollection 2015. PMID: 26034511; PMCID: PMC4450452.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 43 entries